Amit Akirov1,2, Alexander Gorshtein3,4, Ilana Shraga-Slutzky3,4, Ilan Shimon3,4. 1. Institute of Endocrinology, Beilinson Hospital, Petach Tikva, Israel. amit.akirov@gmail.com. 2. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. amit.akirov@gmail.com. 3. Institute of Endocrinology, Beilinson Hospital, Petach Tikva, Israel. 4. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Abstract
AIM: Investigate the association of calcium levels on admission and change in levels during hospitalization with hospitalization outcomes. METHODS: Historical prospective data of patients hospitalized to units of internal medicine between 2011 and 2013. Albumin-corrected-calcium levels were classified to marked hypocalcemia (<7.5 mg/dL), mild hypocalcemia (7.5-8.5 mg/dL), normal calcium (8.5-10.5 mg/dL), mild hypercalcemia (10.5-11.5 mg/dL), marked hypercalcemia (>11.5 mg/dL). Main outcomes were length-of-hospitalization, in-hospital and long-term mortality. RESULTS: Cohort included 30,813 patients (mean age 67 ± 18 years, 51% male). Follow-up (median ± standard deviation) was 1668 ± 325 days. Most patients had normal calcium on admission (93%), 3% had hypocalcemia, 3% had hypercalcemia. Common causes for marked hypercalcemia were malignancy (56%) and hyperparathyroidism (22%). Last calcium levels before discharge or death were normal in 94%, with similar rates of hypercalcemia or hypocalcemia (3% each). Compared to in-hospital mortality with normal calcium on admission (6%), mortality was higher with mild (8%) and marked hypocalcemia (11%), and highest with mild (18%) and marked hypercalcemia (22%). Mortality rate at the end of follow-up was 48% with normal calcium or mild hypocalcemia, 51% with marked hypocalcemia, 68 and 79% with mild and marked hypercalcemia, respectively. Patients with normal calcium on admission and before discharge had the best prognosis. Hypercalcemia on admission or before discharge was associated with a 70% mortality risk at the end of follow-up. Normalization of admission hypercalcemia had no effect on long-term mortality risk. CONCLUSIONS: Abnormal calcium on admission is associated with increased short-term and long-term mortality. The excess mortality risk is higher with hypercalcemia than hypocalcemia. Calcium normalization before discharge had no effect on mortality.
AIM: Investigate the association of calcium levels on admission and change in levels during hospitalization with hospitalization outcomes. METHODS: Historical prospective data of patients hospitalized to units of internal medicine between 2011 and 2013. Albumin-corrected-calcium levels were classified to marked hypocalcemia (<7.5 mg/dL), mild hypocalcemia (7.5-8.5 mg/dL), normal calcium (8.5-10.5 mg/dL), mild hypercalcemia (10.5-11.5 mg/dL), marked hypercalcemia (>11.5 mg/dL). Main outcomes were length-of-hospitalization, in-hospital and long-term mortality. RESULTS: Cohort included 30,813 patients (mean age 67 ± 18 years, 51% male). Follow-up (median ± standard deviation) was 1668 ± 325 days. Most patients had normal calcium on admission (93%), 3% had hypocalcemia, 3% had hypercalcemia. Common causes for marked hypercalcemia were malignancy (56%) and hyperparathyroidism (22%). Last calcium levels before discharge or death were normal in 94%, with similar rates of hypercalcemia or hypocalcemia (3% each). Compared to in-hospital mortality with normal calcium on admission (6%), mortality was higher with mild (8%) and marked hypocalcemia (11%), and highest with mild (18%) and marked hypercalcemia (22%). Mortality rate at the end of follow-up was 48% with normal calcium or mild hypocalcemia, 51% with marked hypocalcemia, 68 and 79% with mild and marked hypercalcemia, respectively. Patients with normal calcium on admission and before discharge had the best prognosis. Hypercalcemia on admission or before discharge was associated with a 70% mortality risk at the end of follow-up. Normalization of admission hypercalcemia had no effect on long-term mortality risk. CONCLUSIONS: Abnormal calcium on admission is associated with increased short-term and long-term mortality. The excess mortality risk is higher with hypercalcemia than hypocalcemia. Calcium normalization before discharge had no effect on mortality.
Authors: Zhi-Yong Li; Simon Howarth; Tjun Tang; Martin Graves; Jean U-King-Im; Jonathan H Gillard Journal: Cerebrovasc Dis Date: 2007-09-19 Impact factor: 2.762
Authors: Thomas C Sauter; Gregor Lindner; Sufian S Ahmad; Alexander Benedikt Leichtle; Georg-Martin Fiedler; Aristomenis K Exadaktylos; Dominik G Haider Journal: PLoS One Date: 2015-07-14 Impact factor: 3.240
Authors: Vinas-Rios Juan Manuel; Sanchez-Aguilar Martin; Sanchez-Rodriguez Jose Juan; Muruato-Araiza Luis Fernando; Meyer Frerk; Kretschmer Thomas; Heinen Christian Journal: Asian J Neurosurg Date: 2015 Jul-Sep
Authors: Wisit Cheungpasitporn; Charat Thongprayoon; Panupong Hansrivijit; Juan Medaura; Api Chewcharat; Tarun Bathini; Michael A Mao; Stephen B Erickson Journal: Adv Biomed Res Date: 2020-04-22
Authors: A Catalano; D Chilà; F Bellone; G Nicocia; G Martino; I Loddo; N Morabito; S Benvenga; S Loddo Journal: J Clin Transl Endocrinol Date: 2018-05-29
Authors: Luigi Di Filippo; Anna Maria Formenti; Patrizia Rovere-Querini; Michele Carlucci; Caterina Conte; Fabio Ciceri; Alberto Zangrillo; Andrea Giustina Journal: Endocrine Date: 2020-06-12 Impact factor: 3.925